全球健康杂志(英文)(Global Health Journal)

全球健康杂志(英文)(Global Health Journal) 万方维普万方目次

  • 国级普刊
基本信息
  • 主管单位:

    国家卫生健康委员会

  • 主办单位:

    人民卫生出版社有限公司

  • 国际刊号:

    2096-3947;EISSN 2414-6447

  • 国内刊号:

    10-1495/R

  • 学科分类:

    预防医学|卫生学

  • 字数:

    6000-16000

  • 有无基金:

     

  • 周期:

    CN外文-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

    010-59787183(官网电话)

  • 邮箱:

    ghj@pmph.com(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    万方,维普,万方目次

  • 级别:

    国级普刊

期刊简介

《全球健康杂志(英文)(Global Health Journal)》期刊已被查看:

更新频次

单位占比

一作占比

投稿指南

1、投稿方式:在线投稿。

2、官网网址:

http://www.keaipublishing.com/cn/journals/global-health-journal/

投稿系统:https://www.editorialmanager.com/glohj

3、出刊日期:季刊,逢季末月30日出版。

2024年4月16日星期二

《全球健康杂志(英文)》简介

【微信公众号信息】

关于本刊

《全球健康杂志(英文)》(Global Health Journal, GHJ)是国家新闻出版署批准出版的正式医学专业学术期刊(CN:10-1495/R; ISSN:2096-3947)。由国家卫生健康委员会主管,人民卫生出版社有限公司主办并出版。目前为季刊,由我国公共卫生领域权威专家李立明教授担任主编。本刊已被Scopus和Directory of Open Access Journals (DOAJ)等国际数据库成功收录。GHJ云集世界权威专家资源和健康领域精粹,立足高视角、高起点、高水准,深入而全面地探讨全球健康的主要挑战、应对全球健康管理问题、并为全球健康在观念和治理方面的创新指引航向。力求打造成为传播全球健康信息,交流全球健康经验,推广全球健康成果的国际出版平台。主要议题含括公共卫生、重大疾病防控、健康卫生体制和政策、社会疾病负担、老龄化与老年病、健康治理和健康促进、全球卫生外交、精神健康、生殖健康、传染性疾病、慢病防控、环境健康、妇幼保健、营养与食品安全、国际卫生合作、医疗服务、劳动卫生等具有全球意义的健康议题以及健康决定因素等。读者对象为联合国相关机构、卫生行政主管单位、健康产业相关人员、卫生政策制定相关单位及研究人员、高等医学院校相关专业人员、医疗卫生学术团体和研究机构、各类医疗卫生单位以及其他关注“全球健康”领域的人员。

《全球健康杂志(英文)》投稿指南

【官网信息】

Guide for Authors

INTRODUCTION

Types of paper

Contributions falling into the following categories will be considered for publication: [ research articles, reviews, health policy, short communications,editorials, commentaries, letters, perspectives, window for China, bridging Belt and Road countries ].

Please ensure that you select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.

BEFORE YOU BEGIN

For information on Ethics in Publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

include a statement on ethics approval and consent (even where the need for approval was waived)

include the name of the ethics committee that approved the study and the committee's reference number if appropriate

All materials must adhere to high ethical and animal welfare standards. Any use of animals must be based on ethological knowledge and respect for species-specific requirements for health and well-being. A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript.

Consent for publication:

If your research or manuscript contains any individual person's data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.

Competing interests

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using https://www.elsevier.com/declaration-of-competing-interests and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More Information https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing/

Submission declaration

Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.

CRediT author statement

For transparency, all authors are requested to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles : Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review and editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and example https://www.elsevier.com/authors/journal-authors/policies-and-ethics/credit-author-statement

Changes to authorship

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:

Before the accepted manuscript is published: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.

After the accepted manuscript is published: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

……

更多详情:

https://www.keaipublishing.com/en/journals/global-health-journal/guide-for-authors/

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。